Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Lafayette › NPI 1275536799
Hospital

Lafayette General Medical Center INC

Lafayette General Medical Center INC was paid $31.02M by Medicaid between Jan 2018 and Dec 2024, across 234 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.

33Billing provider infoLAFAYETTE GENERAL MEDICAL CENTER INC
LAFAYETTE, LA 70503
33aNPI1275536799assigned 05/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$31.02M
24GClaims903,254
24DCodes billed234
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#13 of 96
Median peer was paid$5.17M
This provider vs. median6.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018124,374$4.09M
2019123,508$4.26M
202095,481$2.78M
2021175,008$4.91M
2022143,375$5.22M
2023149,548$5.95M
2024incomplete91,960$3.82M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 30% 73,545 66,975 $9.40M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 24% 78,713 73,774 $7.32M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 29,898 26,992 $4.02M
80053 Comprehensive metabolic panel 1.7% 77,441 68,165 $519K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 6,788 6,518 $512K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.6% 3,479 1,651 $506K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.6% 4,138 3,701 $483K
0240U 1.5% 5,344 4,691 $464K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.4% 27,173 22,935 $433K
70450 Computed tomography, head or brain; without contrast material 1.2% 4,128 3,644 $387K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 80,069 69,180 $381K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 1,557 1,397 $333K
222 more codes
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.0% 3,821 $321K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 7,064 $295K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 23,669 $285K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 2,301 $284K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,632 $283K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 22,843 $259K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,049 $256K
96361 Intravenous infusion, hydration; each additional hour <1% 8,118 $209K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 6,711 $209K
77386 <1% 1,243 $192K
36415 Collection of venous blood by venipuncture <1% 89,825 $175K
77412 <1% 1,100 $170K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,522 $162K
81025 <1% 25,599 $161K
96375 Therapeutic injection; each additional sequential IV push <1% 8,725 $149K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,273 $137K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,211 $135K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 1,131 $130K
84484 <1% 17,012 $116K
71045 Radiologic examination, chest; single view <1% 8,309 $115K
81001 <1% 50,372 $104K
77336 <1% 2,016 $98K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 830 $98K
G0379 Direct admission of patient for hospital observation care <1% 589 $96K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,840 $89K
71046 Radiologic examination, chest; 2 views <1% 4,419 $87K
0002A <1% 6,421 $81K
J3490 Unclassified drugs <1% 29,487 $75K
99214 Doctor's office visit, returning patient (more involved) <1% 1,580 $74K
0001A <1% 6,176 $70K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 3,318 $65K
87088 <1% 8,671 $56K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 13,331 $55K
84443 Thyroid stimulating hormone (TSH) <1% 4,187 $55K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 1,413 $50K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,532 $43K
80055 <1% 1,604 $36K
83690 <1% 6,997 $34K
G0378 Hospital observation service, per hour <1% 934 $34K
J7030 Infusion, normal saline solution , 1000 cc <1% 4,288 $33K
87631 <1% 403 $29K
86803 <1% 2,696 $29K
80050 General health panel <1% 660 $26K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,008 $26K
99213 Doctor's office visit, returning patient (routine) <1% 756 $24K
82677 <1% 1,054 $24K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,867 $24K
83880 <1% 1,055 $21K
77334 <1% 121 $21K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,911 $20K
87400 <1% 3,237 $20K
84702 <1% 1,375 $20K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,339 $19K
78815 Positron emission tomography (PET) for limited area imaging <1% 84 $19K
72125 Computed tomography, cervical spine; without contrast material <1% 181 $19K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 410 $18K
C1714 Catheter, transluminal atherectomy, directional <1% 18 $18K
86780 <1% 1,839 $18K
87081 <1% 2,751 $17K
82105 <1% 1,103 $16K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 858 $16K
86336 <1% 1,055 $15K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 353 $15K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 77 $15K
0004A <1% 516 $14K
87449 <1% 1,154 $14K
86850 <1% 2,546 $14K
85660 <1% 2,670 $12K
84439 <1% 1,513 $12K
97597 <1% 560 $11K
87340 <1% 1,615 $11K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 245 $11K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 513 $10K
86762 <1% 1,086 $10K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 5,754 $9K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 156 $9K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 130 $8K
86480 <1% 197 $8K
59025 Fetal non-stress test <1% 142 $7K
85027 <1% 1,412 $7K
82077 <1% 823 $7K
77300 <1% 40 $7K
83735 <1% 1,786 $7K
86141 <1% 672 $6K
80061 Lipid panel <1% 588 $6K
80320 <1% 815 $6K
82947 <1% 1,505 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,071 $6K
86900 <1% 2,675 $6K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 37 $6K
86901 <1% 2,667 $6K
76819 Fetal biophysical profile; without non-stress testing <1% 83 $6K
86039 <1% 772 $5K
37252 <1% 14 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 810 $5K
85610 <1% 2,351 $5K
75710 <1% 22 $5K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 326 $5K
81003 <1% 2,896 $4K
C1769 Guide wire <1% 484 $4K
99215 Doctor's office visit, returning patient (complex) <1% 78 $4K
87581 <1% 144 $4K
88174 <1% 235 $4K
82950 <1% 994 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 93 $4K
85018 <1% 1,870 $4K
85014 <1% 1,873 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 464 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 83 $3K
77387 <1% 217 $3K
87486 <1% 117 $3K
86235 <1% 100 $3K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 82 $3K
C1753 Catheter, intravascular ultrasound <1% 14 $3K
C1760 Closure device, vascular (implantable/insertable) <1% 34 $3K
87420 <1% 202 $3K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 49 $2K
86200 <1% 254 $2K
J8597 Antiemetic drug, oral, not otherwise specified <1% 183 $2K
72100 <1% 127 $2K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 49 $2K
81511 <1% 1,464 $2K
0003A <1% 143 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 29 $2K
T2101 Human breast milk processing, storage and distribution only <1% 115 $2K
86431 <1% 535 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,527 $2K
85730 <1% 745 $2K
0071A <1% 90 $2K
83655 <1% 137 $2K
77280 <1% 36 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,976 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 509 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 226 $2K
86738 <1% 107 $2K
86225 <1% 127 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 38 $1K
36902 <1% 27 $1K
87070 <1% 159 $1K
0031A <1% 303 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 221 $1K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 62 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 41 $1K
80048 Basic metabolic panel (calcium, ionized) <1% 1,172 $982.11
0072A <1% 36 $926.79
87521 Neg quan hep c or qual rna <1% 27 $877.25
A9150 Non-prescription drugs <1% 639 $845.44
17250 <1% 24 $844.83
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 369 $832.95
83605 <1% 134 $806.92
80143 <1% 95 $765.45
86769 <1% 34 $758.47
84112 <1% 12 $753.57
99244 Office or other outpatient consultation, moderate to high complexity <1% 170 $698.88
80179 <1% 74 $672.12
J1170 Injection, hydromorphone, up to 4 mg <1% 221 $619.42
0034A <1% 16 $589.96
77067 Screening mammography, bilateral, including computer-aided detection <1% 12 $564.63
72040 <1% 28 $549.58
86140 <1% 150 $507.64
83970 <1% 14 $495.36
82550 <1% 128 $481.28
64483 <1% 84 $446.28
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 26 $425.56
90715 <1% 12 $403.92
99204 Doctor's office visit, new patient (more involved) <1% 13 $340.62
82553 <1% 48 $335.98
87077 <1% 51 $310.53
77063 Screening digital breast tomosynthesis, bilateral <1% 12 $306.46
85651 <1% 77 $286.09
81222 <1% 605 $285.89
73564 <1% 15 $272.58
74019 <1% 12 $249.44
J2704 Injection, propofol, 10 mg <1% 1,475 $229.10
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 174 $218.07
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 994 $216.31
87184 <1% 28 $168.52
J0780 Injection, prochlorperazine, up to 10 mg <1% 38 $161.18
84481 <1% 15 $145.92
83090 <1% 17 $143.36
87040 <1% 19 $123.84
86787 <1% 15 $115.92
85379 <1% 14 $111.98
86003 <1% 43 $102.73
85007 <1% 39 $101.61
84156 <1% 45 $99.09
82248 <1% 18 $82.28
82150 <1% 13 $80.08
82247 <1% 17 $77.44
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 32 $74.91
J2060 Injection, lorazepam, 2 mg <1% 28 $63.80
J1790 Injection, droperidol, up to 5 mg <1% 15 $61.84
80047 <1% 23 $58.46
82570 <1% 21 $56.98
84100 <1% 13 $56.88
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 27 $49.42
80076 <1% 22 $48.14
89240 <1% 73 $42.59
91300 <1% 5,517 $31.67
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 18 $27.93
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,245 $25.28
36416 <1% 14 $23.85
85652 <1% 12 $21.60
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 23 $14.21
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 15 $9.90
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 92 $4.76
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 610 $2.75
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 35 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 572 $0.00
11045 0% 41 $0.00
99153 Mod sedat endo service >5yrs 0% 247 $0.00
A9270 Non-covered item or service 0% 226 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 57 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 17 $0.00
91305 0% 12 $0.00
80329 0% 54 $0.00
91303 0% 43 $0.00
99152 0% 423 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 713 $0.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 386 $0.00
76937 0% 150 $0.00
J2800 Injection, methocarbamol, up to 10 ml 0% 32 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGANDY, PATRICK (CEO)
Same official

Other billing entities under GANDY, PATRICK

Full network →
ProviderLocationPaid
Lafayette General Medical Center INCLafayette, LA$368K
Acadiana Imaging Services LLCLafayette, LA$318K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.